Published in Sante Ment Que on January 01, 2008
A follow-up study on the quality of alcohol dependence-related information on the web. Subst Abuse Treat Prev Policy (2011) 0.83
Quality of Web-based information on obsessive compulsive disorder. Neuropsychiatr Dis Treat (2013) 0.81
Brief DISCERN, six questions for the evaluation of evidence-based content of health-related websites. Patient Educ Couns (2009) 1.17
Khat use: lifestyle or addiction? J Psychoactive Drugs (2009) 1.05
Motivations to play specifically predict excessive involvement in massively multiplayer online role-playing games: evidence from an online survey. Eur Addict Res (2011) 1.00
Psychological predictors of problematic involvement in massively multiplayer online role-playing games: illustration in a sample of male cybercafé players. Psychopathology (2011) 0.97
Quality of web-based information on social phobia: a cross-sectional study. Depress Anxiety (2008) 0.95
Quality of web-based information on bipolar disorder. J Affect Disord (2008) 0.94
Topiramate in opiate withdrawal- comparison with clonidine and with carbamazepine/mianserin. Subst Abus (2004) 0.94
Validation of a short French version of the UPPS-P Impulsive Behavior Scale. Compr Psychiatry (2011) 0.92
Quality of Web-based information on depression. Depress Anxiety (2010) 0.90
Lack of inhibitory control predicts cigarette smoking dependence: evidence from a non-deprived sample of light to moderate smokers. Drug Alcohol Depend (2010) 0.88
Trait gambling cognitions predict near-miss experiences and persistence in laboratory slot machine gambling. Br J Psychol (2011) 0.88
Anticonvulsant drugs in the treatment of substance withdrawal. Drugs Today (Barc) (2004) 0.87
The relationship between addiction and religion and its possible implication for care. Subst Use Misuse (2010) 0.85
The Beck Cognitive Insight Scale in outpatients with psychotic disorders: further evidence from a French-speaking sample. Can J Psychiatry (2008) 0.84
Validation of the French version of the alcohol, smoking and substance involvement screening test (ASSIST). Eur Addict Res (2011) 0.84
A follow-up study on the quality of alcohol dependence-related information on the web. Subst Abuse Treat Prev Policy (2011) 0.83
Mirtazapine in drug-induced excessive sweating. Eur J Clin Pharmacol (2005) 0.81
Quality of Web-based information on obsessive compulsive disorder. Neuropsychiatr Dis Treat (2013) 0.81
Psychopharmacological treatment in pathological gambling: a critical review. Curr Pharm Des (2011) 0.81
Loss of STOP protein impairs peripheral olfactory neurogenesis. PLoS One (2010) 0.80
Does the form or the amount of exposure make a difference in the cognitive-behavioral therapy treatment of social phobia? J Nerv Ment Dis (2009) 0.80
Validation of the French version of the alcohol, smoking and substance involvement screening test (ASSIST) in the elderly. Subst Abuse Treat Prev Policy (2012) 0.79
Local back massage with an automated massage chair: general muscle and psychophysiologic relaxing properties. J Altern Complement Med (2005) 0.79
Alcohol-related brief intervention in patients treated for opiate or cocaine dependence: a randomized controlled study. Subst Abuse Treat Prev Policy (2011) 0.79
Cannabis and psychosis. Lancet (2007) 0.78
Impact of psychiatrists' qualifications on the rate of compulsory admissions. Psychiatr Q (2013) 0.78
Topiramate-induced weight loss is possibly due to the blockade of conditioned and automatic processes. Eur J Clin Pharmacol (2007) 0.77
Naltrexone-assisted rapid methadone discontinuation: a pilot study. Eur Addict Res (2007) 0.77
The Geneva Appetitive Alcohol Pictures (GAAP): development and preliminary validation. Eur Addict Res (2011) 0.77
Swiss psychiatrists' beliefs and attitudes about internet addiction. Psychiatr Q (2009) 0.77
Cannabis and the course of schizophrenia. Am J Psychiatry (2008) 0.76
The potential interest of topiramate in addiction. Curr Pharm Des (2011) 0.76
Improvement of cognitive performance by topiramate: Blockage of automatic processes may be the underlying mechanism. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.76
Topiramate for smoking cessation and the importance to distinguish withdrawal-motivated consumption and cue-triggered automatisms. J Clin Psychopharmacol (2009) 0.75
Increased risk of gastrointestinal adverse effects under SSRI/NSAID combination may be due to pharmacokinetic interactions. Br J Clin Pharmacol (2005) 0.75
Pornographic effect of olanzapine: induction of vivid intrusive sexual obsessional images. Gen Hosp Psychiatry (2006) 0.75
Swiss psychiatrists beliefs and attitudes about cannabis risks in psychiatric patients: ideologically determined or evidence-based? Community Ment Health J (2007) 0.75
Understanding Swiss drug policy change and the introduction of heroin maintenance treatment. Eur Addict Res (2014) 0.75
The "rut metaphor": a conceptualization of attractor-shaping properties of addictive drugs. Subst Use Misuse (2008) 0.75
[How hypervigilance and hyperreactivity clinically described in anxiety expressed physiologically?]. Sante Ment Que (2004) 0.75
Obsessive-compulsive symptoms precipitated by methadone tapering. J Clin Psychopharmacol (2004) 0.75
[Pharmacotherapy of anxiety in the addicted patient]. Rev Med Suisse Romande (2004) 0.75
Tragic logic or how evidence does not change convictions: the perception of Geneva's addictology caregivers concerning the utility of disulfiram. J Addict Nurs (2012) 0.75
[The quality of Internet medical sites]. Rev Med Suisse (2007) 0.75
Escitalopram/reboxetine combination in depressed patients with substance use disorder. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.75
[Addiction]. Rev Med Suisse (2015) 0.75
Venlafaxine versus applied relaxation for generalized anxiety disorder: a randomized controlled study on clinical and electrophysiological outcomes. Psychiatr Q (2015) 0.75
Mania after venlafaxine withdrawal in a patient with generalized anxiety disorder. Ann Pharmacother (2007) 0.75
Quality of Smartphone Apps Related to Alcohol Use Disorder. Eur Addict Res (2016) 0.75